Banking on the future: biobanking for "omics" approaches to biomarker discovery for Opisthorchis-induced cholangiocarcinoma in Thailand.
暂无分享,去创建一个
Jason Mulvenna | Alex Loukas | A. Loukas | P. Brindley | J. Mulvenna | J. Bethony | Paul J Brindley | Banchob Sripa | B. Sripa | Ponlapat Yonglitthipagon | Jeffrey M Bethony | Ponlapat Yonglitthipagon
[1] B. Sripa. Pathobiology of opisthorchiasis: an update. , 2003, Acta tropica.
[2] M. Haswell-Elkins,et al. Epidemiology of Opisthorchis viverrini. , 2003, Acta tropica.
[3] G. Gores,et al. Cholangiocarcinoma: modern advances in understanding a deadly old disease. , 2006, Journal of hepatology.
[4] Y. Mizuguchi,et al. MicroRNA profiling of human intrahepatic cholangiocarcinoma cell lines reveals biliary epithelial cell-specific microRNAs. , 2009, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.
[5] D. Larsimont,et al. The role of the pathologist in tissue banking: European Consensus Expert Group Report , 2010, Virchows Archiv.
[6] S. Taylor-Robinson,et al. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. , 2008, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[7] M. Haswell-Elkins,et al. Relationship between intensity of Opisthorchis viverrini infection and hepatobiliary disease detected by ultrasonography , 1992, Journal of gastroenterology and hepatology.
[8] S. Lowe,et al. miR-221 overexpression contributes to liver tumorigenesis , 2009, Proceedings of the National Academy of Sciences.
[9] Lingyun Huang,et al. Serum levels of variants of transthyretin down‐regulation in cholangiocarcinoma , 2008, Journal of cellular biochemistry.
[10] K. Straif,et al. A review of human carcinogens--Part B: biological agents. , 2009, The Lancet. Oncology.
[11] C. Pairojkul,et al. Cholangiocarcinoma: lessons from Thailand , 2008, Current opinion in gastroenterology.
[12] D. Brenner,et al. What goes up must come down: The emerging role of microRNA in fibrosis , 2011, Hepatology.
[13] G. Gores,et al. Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment , 2008, Hepatology.
[14] M. Haswell-Elkins,et al. Reversal of biliary tract abnormalities associated with Opisthorchis viverrini infection following praziquantel treatment. , 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[15] J. Utzinger,et al. Emerging Foodborne Trematodiasis , 2005, Emerging infectious diseases.
[16] P. Selby,et al. Circulating markers of biliary malignancy: opportunities in proteomics? , 2008, The Lancet. Oncology.
[17] R. Andrews,et al. Opisthorchis viverrini: an underestimated parasite in world health. , 2008, Trends in parasitology.
[18] M. Haswell-Elkins,et al. Cross‐sectional study of Opisthorchis viverrini infection and cholangiocarcinoma in communities within a high‐risk area in northeast thailand , 1994, International journal of cancer.
[19] D. Parkin,et al. Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[20] Yoshiki Murakami,et al. The Progression of Liver Fibrosis Is Related with Overexpression of the miR-199 and 200 Families , 2011, PloS one.
[21] S. Pinlaor,et al. Hepatobiliary changes, antibody response, and alteration of liver enzymes in hamsters re-infected with Opisthorchis viverrini. , 2004, Experimental parasitology.
[22] Banchob Sripa,et al. Liver Fluke Induces Cholangiocarcinoma , 2007, PLoS medicine.
[23] D. Parkin,et al. The global health burden of infection‐associated cancers in the year 2002 , 2006, International journal of cancer.
[24] B. Sitek,et al. Cell-based proteome analysis: the first stage in the pipeline for biomarker discovery. , 2009, Biochimica et biophysica acta.
[25] Eiliv Lund,et al. Systems Epidemiology in Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.
[26] H. Esumi,et al. Liver fluke infection and cholangiocarcinoma: model of endogenous nitric oxide and extragastric nitrosation in human carcinogenesis. , 1994, Mutation research.
[27] Alex Loukas,et al. Advanced periductal fibrosis from infection with the carcinogenic human liver fluke Opisthorchis viverrini correlates with elevated levels of interleukin‐6 , 2009, Hepatology.
[28] P. Pisani,et al. Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand , 2004, Tropical medicine & international health : TM & IH.
[29] B. Kramer,et al. Trends in biomarker research for cancer detection. , 2001, The Lancet. Oncology.
[30] G. Gores,et al. MicroRNA‐21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3 , 2009, Hepatology.
[31] P. Sithithaworn,et al. Opisthorchis viverrini and opisthorchiasis: the 21st century review. , 2003, Acta tropica.